Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TCT 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

TCT Daily Staff

November 03, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky

October 31, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

Advertisement

Quantitative Flow Ratio Shows Potential in Cath Lab

When to Use Cerebral Protection During TAVR

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Valve Deterioration and Durability Definitions Now Standardized in New Guide

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content